depression and semaglutide The GLP-1 (#Ozempic) failed to improve mood executive functioning in this, the first RCT of a GLP-1 for major #depression: Popular Weight Loss Drugs Like

For instance, on December 2, 2024, the American Diabetes Association (ADA) released a guidance statement on the use of compounded GLP-1 RA (glucagon-like peptide-1 receptor agonist) and dual GIP/GLP-1 RA (glucose-dependent insulinotropic polypeptide and GLP-1 RA) medication classes

The World Anti-Doping Agency (WADA) does not currently list GLP-1 receptor agonists as prohibited substances

This will come as great news for patients who have wanted to try GLP-1 treatments but were needle averse

Bossowski A, Moniuszko M, Dbrowska M, et al

Probably not in any meaningful way

The process for restarting or adjusting semaglutide after a pause or dose modification is straightforward